ABSTRACT
Background Acute kidney injury (AKI) is frequently associated with COVID-19 and the need for kidney replacement therapy (KRT) is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting the need for KRT in hospitalized COVID-19 patients.
Methods This study is part of the multicentre cohort, the Brazilian COVID-19 Registry. A total of 5,212 adult COVID-19 patients were included between March/2020 and September/2020. We evaluated four categories of predictor variables: (1) demographic data; (2) comorbidities and conditions at admission; (3) laboratory exams within 24 h; and (4) the need for mechanical ventilation at any time during hospitalization. Variable selection was performed using generalized additive models (GAM) and least absolute shrinkage and selection operator (LASSO) regression was used for score derivation. The accuracy was assessed using the area under the receiver operating characteristic curve (AUC-ROC). Risk groups were proposed based on predicted probabilities: non-high (up to 14.9%), high (15.0 – 49.9%), and very high risk (≥ 50.0%).
Results The median age of the model-derivation cohort was 59 (IQR 47-70) years, 54.5% were men, 34.3% required ICU admission, 20.9% evolved with AKI, 9.3% required KRT, and 15.1% died during hospitalization. The validation cohort had similar age, sex, ICU admission, AKI, required KRT distribution and in-hospital mortality. Thirty-two variables were tested and four important predictors of the need for KRT during hospitalization were identified using GAM: need for mechanical ventilation, male gender, higher creatinine at admission, and diabetes. The MMCD score had excellent discrimination in derivation (AUROC = 0.929; 95% CI 0.918–0.939) and validation (AUROC = 0.927; 95% CI 0.911–0.941) cohorts an good overall performance in both cohorts (Brier score: 0.057 and 0.056, respectively). The score is implemented in a freely available online risk calculator (https://www.mmcdscore.com/).
Conclusion The use of the MMCD score to predict the need for KRT may assist healthcare workers in identifying hospitalized COVID-19 patients who may require more intensive monitoring, and can be useful for resource allocation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported in part by Minas Gerais State Agency for Research and Development (Fundação de Amparo à Pesquisa do Estado de Minas Gerais –FAPEMIG) [grant number APQ–00208–20] and National Institute of Science and Technology for Health Technology Assessment (Instituto de Avaliação de Tecnologias em Saúde–IATS)/ National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico –CNPq) [grant number 465518/2014–1].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by Brazilian National Committee for Ethics in Research - CONEP (CAAE - Certificate of presentation of Ethical Appreciation: 30350820.5.1001.0008)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Ramos LEF, luckermos19{at}gmail.com, Silva RT, rafaelsilva{at}posteo.net, Pires MC, magda{at}est.ufmg.br, Ponce D, daniela.ponce{at}unesp.br, Carvalho RLR, rafaelsjdr{at}hotmail.com, Schwarbold AV, alexvspoa{at}gmail.com, Maurílio AO,amandaoliveira.maurilio{at}gmail.com, Scotton ALBA, analuiza.bahia{at}yahoo.com.br, Garbini AF, andrygarbini{at}hotmail.com, Farace BL, barbarafarace{at}gmail.com, Garcia BM, barbaramgarcia1234{at}gmail.com, Silva CTCA, carlatcas{at}gmail.com, Cimini CCR, christiane.cimini{at}gmail.com, Carvalho CA, carvalho.cintiaa{at}gmail.com, Dias CS, cristianedias{at}ufmg.br, Silveira DV, danielvez{at}gmail.com, Manenti ERF, eulermanenti{at}gmail.com, Cenci EPA, assistencial6_hu{at}centrodepesquisaclinica.com.br, Anschau F, afernando{at}ghc.com.br, Aranha FG, fgaranha{at}icloud.com, Aguiar FC, filipe.carrilhoag{at}gmail.com, Bartolazzi F, fredlazzi{at}hotmail.com, Vietta GG, ggvietta{at}gmail.com, Nascimento GF, guilhermefagundesn{at}hotmail.com, Noal HC, helenacnoal{at}gmail.com, Duani H, hduani{at}yahoo.com.br, Vianna HR, hrvianna{at}hotmail.com, Guimarães HC, hcerqueirag{at}gmail.com, Alvarenga JC, joice-alvarenga{at}hotmail.com, Chatkin JM, jmchatkin{at}pucrs.br, Moraes JPD, juliadrumond{at}hotmail.com, Machado-Rugolo J, jr.machado{at}unesp.br, Ruschel KB, karenbruschel{at}gmail.com, Martins KPM, kkpmprado2{at}gmail.com, Menezes LSM, luannasmonteiro{at}gmail.com, Couto LSF, lucianasiuves{at}gmail.com, Castro LC, pharmlucamsc{at}gmail.com, Nasi LA, lnasi{at}terra.com.br, Cabral MAS, madersonalvares{at}hotmail.com, Floriani MA, maiara.floriani{at}hmv.org.br, Souza MD, mairadiassouza{at}gmail.com, Souza-Silva MVR, mairavsouza{at}gmail.com, Carneiro M, marceloc{at}unisc.br, Godoy MF, mfdegodoy{at}gmail.com, Bicalho MAC, macbicalho{at}gmail.com, Lima MCPB, mariaclarapontellobl{at}gmail.com, Nogueira MCA, mathnogueira42{at}gmail.com, Martins MFL, matheus_flm{at}hotmail.com, Guimarães Júnior MH, miltonhenriques{at}yahoo.com.br, Sampaio NCS, natsamster{at}gmail.com, Oliveira NR, neimyramos{at}gmail.com, Ziegelmann PK, patriciakz99{at}gmail.com, Andrade PGS, peuguido{at}icloud.com, Assaf PL, pedro.ledic{at}hmdcc.com.br, Martelli PJL, petroniocarla{at}uol.com.br, Delfino-Pereira P, polidelfino{at}yahoo.com.br, Martins RC, rapahaelcm{at}gmail.com, Menezes RM, rochelemenezes{at}unisc.br, Francisco SC, saionaracf{at}gmail.com, Araújo SF, silviaferreiragastro{at}gmail.com, Oliveira TF, talitafischeroliveira{at}gmail.com, Oliveira TC, thainarastaehler{at}hotmail.com, Sales TLS, thaislorennass30{at}yahoo.com.br, Ramires YC, yuri.ramires{at}gmail.com, Marcolino MS, milenamarc{at}gmail.com
Data Availability
All data produced in the present study are available upon reasonable request to the authors
List of abbreviations
- AKI
- acute kidney injury
- ARDS
- acute respiratory distress syndrome
- AUROC
- area under the receiver operating characteristic
- BMI
- body mass index
- BPM1
- beats per minute
- BPM2
- breaths per minute
- CI
- confidence interval
- COPD
- chronic obstructive pulmonary disease
- COVID-19
- Coronavirus disease 19
- GAM
- generalized additive models
- GBT
- gradient boosted trees
- ICU
- intensive care unit
- IL-6
- interleukin-6
- IQR
- interquartile range
- KDIGO
- Kidney Disease Improving Global Outcomes
- KRT
- kidney replacement therapy
- LASSO
- least absolute shrinkage and selection operator
- MICE
- multiple imputation with chained equations
- MMCD
- mechanical ventilation, male, creatinine, diabetes
- MV
- mechanical ventilation
- pCO2
- partial pressure of carbon dioxide
- PEEP
- positive end-expiratory pressure
- PMM
- Predictive mean matching
- PO2
- partial pressure of oxygen
- PROBAST
- Prediction model Risk Of Bias Assessment Tool
- REDCap
- Research Electronic Data Capture
- SBP
- systolic blood pressure
- SF ratio
- SpO2/FiO2 ratio
- SOFA
- Sepsis-related Organ Failure Assessment
- TRIPOD
- Transparent Reporting of a Multivariable Prediction Model for Individual Prediction or Diagnosis
- USA
- United States of America
